Reference
Moulis G, et al. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. Rheumatology 53: 1864-71, No. 10, Oct 2014. Available from: URL: http://doi.org/10.1093/rheumatology/keu214 - France
Rights and permissions
About this article
Cite this article
Adalimumab/etanercept/infliximab. Reactions Weekly 1559, 17 (2015). https://doi.org/10.1007/s40278-015-3206-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-3206-x